Prospective Study of Quality of Life in Non-small Cell Lung Cancer (NSCLC) Patients Treated With/Without Postoperative Radiotherapy

NCT01112631 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 293

Last updated 2011-09-20

No results posted yet for this study

Summary

The patients from 12 centers were included into the study. pN2 patients received PORT, pN1 patients did not. PORT was 3D-planned and consisted in 54-56 Gy in 27-28 fractions. One month after surgery, all patients completed EORTC QLQ C-30 questionnaires and had pulmonary function tests (PFT); cardiopulmonary symptoms were assessed by modified LENT-SOM score. Two years after, all patients free of disease repeated the same examinations. Changes in QLQ, LENT-SOM score and the results of PFT were compared for patients receiving and not PORT.

Conditions

Sponsors & Collaborators

  • Institute of Tuberculosis and Lung Diseases in Warsaw

    collaborator UNKNOWN
  • The Greater Poland Centre of Lung Diseases and Tuberculosis in Poznan

    collaborator UNKNOWN
  • The Greater Poland Cancer Centre

    collaborator OTHER
  • Cancer Centre in Bydgoszcz

    collaborator UNKNOWN
  • Kujawsko-Pomorskie Center of Pulmonology in Bydgoszcz

    collaborator UNKNOWN
  • Specialized Hospital in Zdunowo - Szczecin

    collaborator UNKNOWN
  • Regional Cancer Hospital - Szczecin

    collaborator UNKNOWN
  • Medical University of Gdansk

    collaborator OTHER
  • Holycross Cancer Center in Kielce

    collaborator UNKNOWN
  • Department of Thoracic Surgery - Wrocław

    collaborator UNKNOWN
  • Department of Radiotherapy - Olsztyn

    collaborator UNKNOWN
  • Department of Thoracic Surgery - Łódź

    collaborator UNKNOWN
  • Lower Silesian Oncology Center - Wroclaw

    collaborator UNKNOWN
  • Regional Specialized Hospital -Chęciny, Czerwona Góra

    collaborator UNKNOWN
  • Department of Thoracic Surgery - Otwock

    collaborator UNKNOWN
  • Medical University of Łódź

    collaborator OTHER
  • Maria Sklodowska-Curie National Research Institute of Oncology

    lead OTHER

Principal Investigators

  • Krzysztof Bujko, Prof. · Roentgena 5, 02-781 Warsaw, Poland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30
Primary Completion
2007-09-30
Completion
2007-09-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01112631 on ClinicalTrials.gov